OS Therapies OSTX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -610.8%-184pp | -464.6%-184pp | -334.6%— | -245.1%— | -426.5%— | |
| Liquidity | ||||||
| Current ratio | 0.1×-1.1× | 0×-1.2× | 0.6×-0.2× | 1×+1.0× | 1.2×+1.1× | |
| Quick ratio | 0.1×-1.1× | 0×-1.2× | 0.6×-0.2× | 1×+1.0× | 1.2×+1.1× | |
| Cash ratio | 0.1×-0.8× | 0×-1.2× | 0.5×-0.3× | 0.8×+0.8× | 0.8×+0.8× | |
| Leverage | ||||||
| Debt-to-assets | 2.7×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | -$0.28-42.1% | -$0.21+55.7% | $0.11+356% | $0.20+104% | -$0.20+95.4% | |
| Valuation | ||||||
| Market capitalization | $84.62M+65.5% | $49.3M-45.8% | $62.02M— | $48.33M— | $33.52M— | |
| Enterprise value | $103.7M— | —— | —— | —— | —— | |
| Earnings yield | -41.9%-13.8pp | -58.3%-48.6pp | -29.5%— | -29.5%— | -33.7%— |
Questions, answered.
- Where do OS Therapies's ratios come from?
- Every ratio is computed from OS Therapies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.